Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic Alopecia.
- DOI
- 10.1021/acs.jmedchem.5c03640
- Published
- 2026 Jul 23
- Container
- Journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.jmedchem.5c03640,
title = {Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic Alopecia.},
author = {Zhang Y and Zhang W and Tang F and Huang L and Chen Z and Zhao S and Sun R and Zhang X and Shen X and Hao Y and Lu T and Xie S and Chen Y and Jiao Y},
year = {2026},
journal = {Journal of medicinal chemistry},
doi = {10.1021/acs.jmedchem.5c03640},
url = {https://doi.org/10.1021/acs.jmedchem.5c03640}
}RIS
TY - JOUR TI - Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic Alopecia. AU - Zhang Y AU - Zhang W AU - Tang F AU - Huang L AU - Chen Z AU - Zhao S AU - Sun R AU - Zhang X AU - Shen X AU - Hao Y AU - Lu T AU - Xie S AU - Chen Y AU - Jiao Y PY - 2026 JO - Journal of medicinal chemistry DO - 10.1021/acs.jmedchem.5c03640 UR - https://doi.org/10.1021/acs.jmedchem.5c03640 ER -
APA
Y, Z., W, Z., F, T., L, H., Z, C., S, Z., R, S., X, Z., X, S., Y, H., T, L., S, X., Y, C., & Y, J. (2026). Novel Dual Soft Drug Strategy Enables Development of Topical Androgen Receptor Antagonists with Enhanced Efficacy and Optimized Safety for Androgenetic Alopecia.. Journal of medicinal chemistry. https://doi.org/10.1021/acs.jmedchem.5c03640
Source records
- pubmed · retrieved 2026-09-26T15:24:38.860Z